{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T06:37:14Z","timestamp":1787207834932,"version":"build-2736575974"},"reference-count":135,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.ecl.2005.04.005","type":"journal-article","created":{"date-parts":[[2005,8,6]],"date-time":"2005-08-06T08:31:40Z","timestamp":1123317100000},"page":"677-705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Polycystic Ovary Syndrome in Adolescence"],"prefix":"10.1016","volume":"34","author":[{"given":"Colleen","family":"Buggs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Rosenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2005.04.005_bib1","doi-asserted-by":"crossref","first-page":"S095","DOI":"10.1067\/mjd.2001.117430","article-title":"Polycystic ovary syndrome and insulin-resistant hyperinsulinemia","volume":"45","author":"Rosenfield","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ecl.2005.04.005_bib2","series-title":"Polycystic ovary syndrome","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadzki","year":"1992"},{"key":"10.1016\/j.ecl.2005.04.005_bib3","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/er.16.3.322","article-title":"Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion","volume":"16","author":"Ehrmann","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2005.04.005_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM199207163270304","article-title":"Detection of functional ovarian hyperandrogenism in women with androgen excess","volume":"327","author":"Ehrmann","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2005.04.005_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0889-8529(05)70070-0","article-title":"Ovarian and adrenal function in polycystic ovary syndrome","volume":"28","author":"Rosenfield","year":"1999","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ecl.2005.04.005_bib6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1210\/jcem-70-3-699","article-title":"Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome","volume":"70","author":"Dunaif","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib7","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1210\/jcem-70-4-1096","article-title":"Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism","volume":"70","author":"Rittmaster","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2005.04.005_bib9","first-page":"372","article-title":"Regulation of beta-cell function in vivo: from health to disease","volume":"4","author":"Kahn","year":"1996","journal-title":"Diabetes Reviews"},{"key":"10.1016\/j.ecl.2005.04.005_bib10","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2337\/diacare.21.2.310","article-title":"Consensus Development Conference on Insulin Resistance","volume":"21","author":"American Diabetes Association","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2005.04.005_bib11","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation","author":"Alberti","year":"1999"},{"key":"10.1016\/j.ecl.2005.04.005_bib12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2005.04.005_bib13","first-page":"1285","article-title":"Diagnosis of polycystic ovary syndrome in adolescence. Comparison of adolescent and adult hyperandrogenism","volume":"13","author":"Rosenfield","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib14","first-page":"2691","article-title":"Anovulation after precocious pubarche: early markers and time course in adolescence","volume":"84","author":"Iba\u00f1ez","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib15","first-page":"2966","article-title":"Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism","volume":"80","author":"Apter","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib16","first-page":"119","article-title":"Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome","volume":"79","author":"Apter","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib17","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1210\/jcem.83.10.5205","article-title":"Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism: relation to reduced fetal growth","volume":"83","author":"Iba\u00f1ez","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib18","first-page":"1599","article-title":"Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism","volume":"76","author":"Iba\u00f1ez","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1365-2265.2002.01579.x","article-title":"Endocrine consequences of premature pubarche in postpubertal Caucasian girls","volume":"57","author":"Meas","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2005.04.005_bib20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/eje.0.1330399","article-title":"Are adrenal and ovarian function normal in true precocious puberty?","volume":"133","author":"Rosenfield","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2005.04.005_bib21","first-page":"117A","article-title":"Pseudo-Cushing syndrome and pseudoacromegalic gigantism associated with insulin resistant hyperinsulinism as childhood precursors of polycystic ovary syndrome","volume":"51","author":"Baumann","year":"2002","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ecl.2005.04.005_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2265.1993.tb01767.x","article-title":"17-hydroxyprogesterone response to buserelin testing in the polycystic ovary syndrome","volume":"39","author":"Sahin","year":"1993","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ecl.2005.04.005_bib23","first-page":"895","article-title":"Increased luteinizing hormone and a-subunit secretion in women with hyperandrogenic anovulation","volume":"77","author":"Berga","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib24","first-page":"4047","article-title":"Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone","volume":"85","author":"Eagleson","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib25","first-page":"582","article-title":"Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone","volume":"83","author":"Pastor","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib26","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1210\/jc.2003-030816","article-title":"Increased luteinizing hormone secretion in women with polycystic ovary syndrome is unaltered by prolonged insulin infusion","volume":"88","author":"Patel","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib27","unstructured":"Buggs C, Weinberg F, Wolfe A, et al. Insulin together with GnRH modulates expression of LH beta gene expression. Presented at the Endocrine Society's 85th Annual Meeting. Philadelphia, June 19\u201322, 2003."},{"key":"10.1016\/j.ecl.2005.04.005_bib28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ajog.2004.01.054","article-title":"Insulin enhances the transcription of luteinizing hormone-beta gene","volume":"191","author":"Dorn","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ecl.2005.04.005_bib29","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1210\/jc.2004-0643","article-title":"Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome","volume":"89","author":"Maciel","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib30","first-page":"1318","article-title":"Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries","volume":"86","author":"Jakimiuk","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib31","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1210\/jcem.86.12.8088","article-title":"The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome","volume":"86","author":"Nelson","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib32","first-page":"2304","article-title":"Differential activity of the cytochrome P450 17\u03b1-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells","volume":"85","author":"Wickenheisser","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib33","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1210\/jc.2002-021280","article-title":"Evidence for abnormal granulosa cell responsiveness to follicle-stimulating hormone in women with polycystic ovary syndrome","volume":"88","author":"Coffler","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib34","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1210\/jc.2002-021875","article-title":"Beyond adrenal and ovarian androgen generation: Increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome","volume":"88","author":"Fassnacht","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1677\/joe.1.05762","article-title":"Androgen generation in adipose tissue in women with simple obesity - a site-specific role for 17\u03b2-hydroxysteroid dehydrogenase type 5","volume":"183","author":"Quinkler","year":"2004","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ecl.2005.04.005_bib36","first-page":"3110","article-title":"Selective insulin resistance in the polycystic ovary syndrome","volume":"84","author":"Book","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib37","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1126\/science.289.5487.2122","article-title":"Role of brain insulin receptor in control of body weight and reproduction","volume":"289","author":"Bruning","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ecl.2005.04.005_bib38","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2337\/diacare.24.7.1297","article-title":"Identification of the source of androgen excess in hyperandrogenic type 1 diabetic patients","volume":"24","author":"Roldan","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2005.04.005_bib39","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2003-0004","article-title":"Polycystic ovary syndrome and cardiovascular disease: a premature association?","volume":"24","author":"Legro","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2005.04.005_bib40","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1210\/jc.2004-1136","article-title":"Cardiovascular risk in PCOS","volume":"89","author":"Guzick","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib41","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0015-0282(02)03275-2","article-title":"Molecular progress in infertility: polycystic ovary syndrome","volume":"78","author":"Legro","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2005.04.005_bib42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0015-0282(00)01662-9","article-title":"Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS","volume":"75","author":"Kahsar-Miller","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2005.04.005_bib43","doi-asserted-by":"crossref","first-page":"14956","DOI":"10.1073\/pnas.95.25.14956","article-title":"Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome","volume":"95","author":"Legro","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ecl.2005.04.005_bib44","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/hmg\/3.10.1873","article-title":"Polycystic ovaries and premature male-pattern baldness are associated with one allele of the steroid metabolism gene CYP 17","volume":"3","author":"Carey","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ecl.2005.04.005_bib45","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1210\/jcem.84.1.5382","article-title":"Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families","volume":"84","author":"Govind","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib46","first-page":"1158","article-title":"Hypersecretion of androstenedione by isolated theca cells from polycystic ovaries","volume":"79","author":"Gilling-Smith","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib47","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1210\/jc.2003-031600","article-title":"Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome","volume":"89","author":"Adams","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib48","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2265.1997.2321049.x","article-title":"Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome","volume":"47","author":"Gilling-Smith","year":"1997","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ecl.2005.04.005_bib49","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0140-6736(88)91612-1","article-title":"Polycystic ovaries\u2014a common finding in normal women","volume":"1","author":"Polson","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2005.04.005_bib50","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/mgme.1998.2715","article-title":"Variants of the type II 3\u03b2-hydroxysteroid dehydrogenase gene in children with premature pubic hair and hyperandrogenic adolescents","volume":"64","author":"Nayak","year":"1998","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib51","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/bmme.1997.2632","article-title":"Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency","volume":"62","author":"Witchel","year":"1997","journal-title":"Biochem Mol Med"},{"key":"10.1016\/j.ecl.2005.04.005_bib52","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/mend.13.6.0311","article-title":"Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries","volume":"13","author":"Nelson","year":"1999","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ecl.2005.04.005_bib53","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1073\/pnas.92.23.10619","article-title":"Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome","volume":"92","author":"Zhang","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ecl.2005.04.005_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1740001","article-title":"Developmental origin of polycystic ovary syndrome\u2014a hypothesis","volume":"174","author":"Abbott","year":"2002","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ecl.2005.04.005_bib55","first-page":"1328","article-title":"Ovarian hyperandrogenism as a result of congenital adrenal virilizing disorders: Evidence for perinatal masculinization of neuroendocrine function in women","volume":"79","author":"Barnes","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib56","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/oby.2003.42","article-title":"Increased adiposity in female rhesus monkeys exposed to androgen excess during early gestation","volume":"11","author":"Eisner","year":"2003","journal-title":"Obes Res"},{"key":"10.1016\/j.ecl.2005.04.005_bib57","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2005.04.005_bib58","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0026-0495(03)00104-5","article-title":"Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome","volume":"52","author":"Glueck","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.ecl.2005.04.005_bib59","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1210\/jc.2003-032049","article-title":"The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study","volume":"89","author":"Orio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib60","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2005.04.005_bib61","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib62","first-page":"A818","article-title":"Metabolic syndrome features are the typical parental phenotype of adolescent polycystic ovary syndrome (PCOS)","volume":"55","author":"Leibel","year":"2004","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ecl.2005.04.005_bib63","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1046\/j.1464-5491.2002.00843.x","article-title":"Heritability of features of the insulin resistance syndrome in a community-based study of healthy families","volume":"19","author":"Freeman","year":"2002","journal-title":"Diabet Med"},{"key":"10.1016\/j.ecl.2005.04.005_bib64","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s00125-004-1338-2","article-title":"Heritability estimates for beta cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to type 2 diabetes","volume":"47","author":"Mills","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.ecl.2005.04.005_bib65","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Medical progress: polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2005.04.005_bib66","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/edrv.21.4.0404","article-title":"Role of hormones in pilosebaceous unit development","volume":"21","author":"Deplewski","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2005.04.005_bib67","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9378(81)90746-8","article-title":"Hirsutism: implications, etiology, and management","volume":"140","author":"Hatch","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ecl.2005.04.005_bib68","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1001\/archderm.136.3.430","article-title":"Hyperhidrosis as the only manifestation of hyperandrogenism in an adolescent girl","volume":"136","author":"Kim","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ecl.2005.04.005_bib69","first-page":"251","article-title":"The SAHA syndrome","volume":"54","author":"Orfanos","year":"2000","journal-title":"Horm Res"},{"key":"10.1016\/j.ecl.2005.04.005_bib70","first-page":"77","article-title":"Variation of human menstrual cycle through reproductive life","volume":"12","author":"Treloar","year":"1967","journal-title":"Int J Fertil"},{"key":"10.1016\/j.ecl.2005.04.005_bib71","first-page":"1533","article-title":"Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resistance","volume":"76","author":"Flier","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib72","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0026-0495(98)90210-4","article-title":"Altered morning and nighttime pulsatile corticotropin and cortisol release in polycystic ovary syndrome","volume":"47","author":"Invitti","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.ecl.2005.04.005_bib73","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/153537020422900504","article-title":"Screening for and treatment of polycystic ovary syndrome in teenagers","volume":"229","author":"Salami","year":"2004","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.ecl.2005.04.005_bib74","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1001\/archderm.1994.01690030040006","article-title":"Acne vulgaris in premenarchal girls","volume":"130","author":"Lucky","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ecl.2005.04.005_bib75","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1210\/jcem-45-5-1039","article-title":"Serum pregnenolone, progesterone, 17-hydroxyprogesterone, testosterone, and 5\u03b1-dihydrotestosterone during female puberty","volume":"45","author":"Apter","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib76","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archpedi.157.8.821","article-title":"Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988\u20131994","volume":"157","author":"Cook","year":"2003","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.ecl.2005.04.005_bib77","first-page":"347","article-title":"Idiopathic hirsutism","volume":"21","author":"Azziz","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2005.04.005_bib78","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00019616-200207000-00011","article-title":"Polycystic ovary syndrome in adolescence","volume":"12","author":"Baumann","year":"2002","journal-title":"Endocrinologist"},{"key":"10.1016\/j.ecl.2005.04.005_bib79","first-page":"2946","article-title":"Polycystic ovarian syndrome\u2013relationship to epilepsy and antiepileptic drug therapy","volume":"86","author":"Joffe","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib80","first-page":"810","article-title":"Nonclassic adrenal hyperplasia: current concepts","volume":"78","author":"Azziz","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib81","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib82","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1210\/jc.2002-020922","article-title":"The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women","volume":"88","author":"Kaltsas","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib83","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0015-0282(16)44049-5","article-title":"Pituitary tumors associated with hyperprolactinemia and polycystic ovary disease","volume":"31","author":"Futterweit","year":"1979","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2005.04.005_bib84","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1210\/jcem-55-2-251","article-title":"Multiple androgenic abnormalities, including elevated free testosterone, in hyperprolactinemic women","volume":"55","author":"Glickman","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib85","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1365-2265.2000.01117.x","article-title":"How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?","volume":"53","author":"Kaltsas","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2005.04.005_bib86","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1210\/jcem.84.8.5858","article-title":"Menstrual irregularity in women with acromegaly","volume":"84","author":"Kaltsas","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib87","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0950-3552(97)80039-9","article-title":"Current concepts of polycystic ovary syndrome","volume":"11","author":"Rosenfield","year":"1997","journal-title":"Baillieres Clin Obstet Gynaecol"},{"key":"10.1016\/j.ecl.2005.04.005_bib88","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1210\/jc.2003-030450","article-title":"Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype","volume":"89","author":"Charmandari","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib89","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ng1214","article-title":"Mutations in the genes encoding 11\u03b2-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency","volume":"34","author":"Draper","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.ecl.2005.04.005_bib90","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0002-9378(66)90398-X","article-title":"The prognosis for adolescents with menstrual abnormalities","volume":"94","author":"Southam","year":"1966","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ecl.2005.04.005_bib91","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1373\/49.8.1381","article-title":"Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children","volume":"49","author":"Taieb","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.ecl.2005.04.005_bib92","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/jc.2003-030680","article-title":"Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods","volume":"89","author":"Miller","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib93","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4158\/EP.7.2.120","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of hyperandrogenic disorders","volume":"7","author":"Goodman","year":"2001","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ecl.2005.04.005_bib94","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0002-9343(79)91061-1","article-title":"Plasma free androgen patterns in hirsute women and their diagnostic implications","volume":"66","author":"Rosenfield","year":"1979","journal-title":"Am J Med"},{"key":"10.1016\/j.ecl.2005.04.005_bib95","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1210\/jcem-49-5-730","article-title":"Testosterone binding and free plasma androgen concentrations under physiologic conditions: characterization by flow dialysis technique","volume":"49","author":"Moll","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib96","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/0002-9378(83)90998-5","article-title":"Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism","volume":"146","author":"Wild","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ecl.2005.04.005_bib97","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jcem.76.2.8432767","article-title":"Sex hormone binding globulin: a marker for hyperinsulinemia and\/or insulin resistance?","volume":"76","author":"Nestler","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib98","series-title":"Androgenization in women","first-page":"25","article-title":"The role of proteins in the distribution of plasma androgens and estradiol","author":"Rosenfield","year":"1983"},{"key":"10.1016\/j.ecl.2005.04.005_bib99","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/edrv-11-1-80","article-title":"The functions of corticosteroid-binding globulin and sex hormone binding-globulin: recent advances","volume":"11","author":"Rosner","year":"1990","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2005.04.005_bib100","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0022-3476(83)80678-7","article-title":"Plasma-free testosterone in the diagnosis of adolescent polycystic ovary syndrome","volume":"102","author":"Moll","year":"1983","journal-title":"J Pediatr"},{"key":"10.1016\/j.ecl.2005.04.005_bib101","first-page":"1389","article-title":"ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists.Polycystic ovary syndrome","volume":"100","author":"American College of Obstetrics and Gynecology.","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ecl.2005.04.005_bib102","first-page":"341","article-title":"ACOG technical bulletin. Evaluation and treatment of hirsute women","volume":"49","author":"American College of Obstetrics and Gynecology","year":"1995","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ecl.2005.04.005_bib103","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","article-title":"Ultrasound assessment of the polycystic ovary: international consensus definitions","volume":"9","author":"Balen","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ecl.2005.04.005_bib104","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1203\/00006450-199512000-00024","article-title":"Longitudinal change of sonographic ovarian aspects and endocrine parameters in irregular cycles of adolescence","volume":"38","author":"Venturoli","year":"1995","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ecl.2005.04.005_bib105","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(85)92552-8","article-title":"Multi-follicular ovaries: clinical and endocrine features and response to pulsatile gonadotrophin-releasing hormone","volume":"2","author":"Adams","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2005.04.005_bib106","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1210\/jc.2003-031357","article-title":"The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women","volume":"88","author":"Rosenfield","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib107","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/hmg\/6.11.1829","article-title":"CYP11B1 mutations causing nonclassic adrenal hyperplasia due to 11\u03b2-hydroxylase deficiency","volume":"6","author":"Joehrer","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ecl.2005.04.005_bib108","first-page":"2611","article-title":"Newly proposed hormonal criteria via genotypic proof for type II 3\u03b2-hydroxysteroid dehydrogenase deficiency","volume":"87","author":"Lutfallah","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib109","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0733-8635(03)00052-4","article-title":"Hair removal by lasers and intense pulsed light sources","volume":"20","author":"Dierickx","year":"2002","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.ecl.2005.04.005_bib110","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMcp030751","article-title":"Clinical practice. Combination estrogen-progestin oral contraceptives","volume":"349","author":"Petitti","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2005.04.005_bib111","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2165\/00003495-199651020-00002","article-title":"Comparative pharmacology of newer progestogens","volume":"51","author":"Kuhl","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.ecl.2005.04.005_bib112","first-page":"54","article-title":"A new generation of contraceptives","volume":"66","author":"Akert","year":"2003","journal-title":"RN"},{"key":"10.1016\/j.ecl.2005.04.005_bib113","first-page":"652","article-title":"Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids","volume":"85","author":"Kannisto","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib114","first-page":"3251","article-title":"Treatment of hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism in nonobese, adolescent girls: effect of flutamide","volume":"85","author":"Iba\u00f1ez","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1210\/jcem.83.1.4500","article-title":"Hormonal effects of flutamide in young women with polycystic ovary syndrome","volume":"83","author":"De Leo","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2005.04.005_bib116","article-title":"Spironolactone versus placebo or in combination with steroids for hirsutism and\/or acne","author":"Farquhar","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ecl.2005.04.005_bib117","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1067\/mjd.2001.117426","article-title":"Female-pattern hair loss","volume":"45","author":"Olsen","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ecl.2005.04.005_bib118","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1365-2133.2002.04798.x","article-title":"Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial","volume":"146","author":"Vexiau","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ecl.2005.04.005_bib119","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jcem-62-1-16","article-title":"Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals","volume":"62","author":"Futterweit","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib120","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJM200105173442007","article-title":"Oral contraceptives and the risk of venous thrombosis","volume":"344","author":"Vandenbroucke","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2005.04.005_bib121","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1471-0528.1995.tb09070.x","article-title":"Oral contraceptives, pregnancy, and the risk of cerebral thromboembolism: The influence of diabetes, hypertension, migraine, and previous thrombotic disease","volume":"102","author":"Lidegaard","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ecl.2005.04.005_bib122","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(04)17274-7","article-title":"Oestrogen treatment to reduce the adult height of tall girls: long-term effects on fertility","volume":"364","author":"Venn","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2005.04.005_bib123","first-page":"1470","article-title":"Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone","volume":"84","author":"Huber-Buchholz","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib124","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ecl.2005.04.005_bib125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1210\/jcem-68-1-173","article-title":"Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss","volume":"68","author":"Pasquali","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib126","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-137-1-200207020-00009","article-title":"Metformin: an update","volume":"137","author":"Kirpichnikov","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ecl.2005.04.005_bib127","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMra041001","article-title":"Thiazolidinediones","volume":"351","author":"Yki-Jarvinen","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2005.04.005_bib128","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(03)13493-9","article-title":"Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome","volume":"361","author":"Harborne","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ecl.2005.04.005_bib129","article-title":"Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome","author":"Lord","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ecl.2005.04.005_bib130","doi-asserted-by":"crossref","first-page":"16767","DOI":"10.1074\/jbc.M100040200","article-title":"Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3\u03b2-hydroxysteroid dehydrogenase","volume":"276","author":"Arlt","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ecl.2005.04.005_bib131","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0015-0282(02)04925-7","article-title":"Metformin has direct effects on human ovarian steroidogenesis","volume":"79","author":"Mansfield","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2005.04.005_bib132","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2004.02.127","article-title":"Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity","volume":"82","author":"Baillargeon","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2005.04.005_bib133","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1210\/jc.2004-0463","article-title":"Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment","volume":"89","author":"Ibanez","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.04.005_bib134","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0950-3552(97)80040-5","article-title":"Relation of functional ovarian hyperandrogenism to noninsulin-dependent diabetes mellitus","volume":"11","author":"Ehrmann","year":"1997","journal-title":"Bailli\u00e8res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ecl.2005.04.005_bib135","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1210\/jc.2003-031737","article-title":"Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome","volume":"89","author":"Brettenthaler","year":"2004","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985290500040X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985290500040X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:20:25Z","timestamp":1760174425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985290500040X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":135,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S088985290500040X"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2005.04.005","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polycystic Ovary Syndrome in Adolescence","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2005.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}